From January 1, 2024 to March 31, 2024, the company has repurchased 310,912 shares, representing 0.23% for CNY 14.91 million. With this, the company has completed the repurchase of 607,326 shares, representing 0.45% for CNY 34.9 million under the buyback announced on November 13, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
27.01 CNY | -6.48% |
|
-8.75% | -60.50% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-60.50% | 501M | |
+16.73% | 123B | |
+21.13% | 115B | |
+18.05% | 25.85B | |
-17.94% | 20.9B | |
-16.24% | 16.52B | |
-11.76% | 16.77B | |
-44.45% | 15.56B | |
+69.92% | 15.49B | |
+1.41% | 13.45B |
- Stock Market
- Equities
- 688202 Stock
- News Shanghai Medicilon Inc.
- Tranche Update on Shanghai Medicilon Inc.'s Equity Buyback Plan announced on November 13, 2023.